Transmedics Group Inc buy BiotechBee
Start price
29.04.24
/
70%
€88.94
Target price
31.05.26
€130.00
Performance (%)
-30.63%
End price
14.12.24
€61.70
Summary
This prediction ended on 14.12.24 with a price of €61.70. Massive losses of -30.63% were the result for the BUY prediction by BiotechBee. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Transmedics Group Inc | 10.447% | 10.447% | 35.765% |
| iShares Core DAX® | 3.023% | 2.202% | 14.664% |
| iShares Nasdaq 100 | 3.561% | 1.325% | 31.410% |
| iShares Nikkei 225® | 6.618% | 5.707% | 49.420% |
| iShares S&P 500 | 2.635% | 1.008% | 25.116% |
According to BiotechBee what are the pros and cons of Transmedics Group Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Transmedics Group Inc diskutieren
Buy mit Kursziel 130,0